Perceptual Abnormalities and Their Malleability in BDD

Last updated: June 20, 2024
Sponsor: Centre for Addiction and Mental Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bulimia

Anxiety Disorders

Hypochondriasis

Treatment

perceptual modulation

attentional modulation

naturalistic viewing

Clinical Study ID

NCT04373629
R01MH121520-01A1
R01MH121520
  • Ages 18-40
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A core symptom of body dysmorphic disorder (BDD) is perceptual distortions for appearance, which contributes to poor insight and delusionality, limits engagement in treatment, and puts individuals at risk for relapse. Results from this study will provide a comprehensive mechanistic model of brain, behavioral, and emotional contributors to abnormal perceptual processing, as well as how malleable it is with visual modulation techniques. This will lay the groundwork for next-step translational perceptual retraining approaches.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Body dysmorphic disorder: Inclusion:

  • males or females

  • ages 18-40

  • meet Diagnostic and Statistical Manual-5 (DSM-5) criteria for Body DysmorphicDisorder

  • have a Body Dysmorphic Disorder version of the Yale-Brown Obsessive-CompulsiveDisorder Scale (BDD-YBOCS) score of ≥20

  • primary appearance concerns of the face or head area

  • medication naïve or medication free for at least 8 weeks prior to enrollment

Inclusion Criteria:

Subclinical body dysmorphic disorder: Inclusion:

  • males or females

  • ages 18-40

  • have a score on the Dysmorphic Concern Questionnaire of ≥8 [1 standard deviation (STD) above population norms] - primary appearance concerns of the face or head area

  • medication naïve or medication free for at least 8 weeks prior to enrollment

Inclusion Criteria:

Healthy controls: Inclusion

  • Healthy males and females from any racial or ethnic background - ages 18-40

  • have a score on the Dysmorphic Concern Questionnaire of <8

Exclusion

Exclusion Criteria:

Body dysmorphic disorder: Exclusion

  • concurrent major Axis I disorders including substance use disorders, aside fromanxiety disorders or depressive disorders, as these comorbidities are very commonand the sample would otherwise be non-representative; however BDD must be theprimary diagnosis.

  • lifetime: bipolar disorder or psychotic disorder.

  • psychotropic medications, aside from a short half-life sedative/hypnotic forinsomnia, or a short half-life benzodiazepine as needed for anxiety but notexceeding a frequency of 3 doses in one week and not to be taken on the days of thetraining or MRI scan

  • current cognitive-behavioral therapy

Exclusion:

Subclinical body dysmorphic disorder: Exclusion

  • meet full DSM-5 criteria for Body Dysmorphic Disorder

  • current Axis I disorders including substance use disorders

  • lifetime: bipolar disorder or psychotic disorder

  • psychotropic medications, aside from a short half-life sedative/hypnotic forinsomnia, or a short half-life benzodiazepine as needed for anxiety but notexceeding a frequency of 3 doses in one week and not to be taken on the days of thetraining or MRI scan

  • current cognitive-behavioral therapy

Exclusion Criteria:

Healthy Controls: Exclusion

  • Any current Axis I disorder

  • lifetime: bipolar disorder or psychotic disorder

  • Psychiatric medication

Exclusion Criteria:

All participants: Exclusion

  • Neurological disorder

  • Pregnancy

  • Current major medical disorders that may affect cerebral metabolism such as diabetesor thyroid disorders - Current risk of suicide with a plan and intent

  • Ferromagnetic metal implantations or devices (electronic implants or devices,infusion pumps, aneurysm clips, metal fragments or foreign bodies, metal prostheses,joints, rods or plates)

  • Visual acuity worse than 20/35 for each eye as determined by Snellen close visionacuity chart (vision will be tested with corrective lenses if participant usesthem).

Study Design

Total Participants: 146
Treatment Group(s): 3
Primary Treatment: perceptual modulation
Phase:
Study Start date:
December 01, 2020
Estimated Completion Date:
December 01, 2025

Study Description

Individuals with body dysmorphic disorder (BDD) misperceive specific aspects of one's own appearance to be conspicuously flawed or defective, despite these being unnoticeable or appearing minuscule to others. With convictions of disfigurement and ugliness, individuals with BDD typically have poor insight or delusional beliefs, obsessive thoughts and compulsive behaviors, anxiety, and depression. These result in significant difficulties in functioning, depression, suicide attempts (25%), and psychiatric hospitalization (50%). Despite this, relatively few studies of the neurobiology, and few treatment studies, have been conducted. This underscores a critical need for research to identify novel targets for intervention based on a comprehensive understanding of the pathophysiological mechanisms. Neuropsychological, behavioral, and neurobiological research by investigators have uncovered mechanisms that may contribute to perceptual distortions, including prominent abnormalities in visual processing systems. These have contributed to a model of diminished global/holistic processing and enhanced local/detailed processing, attributed to "bottom-up" and "top-down" disturbances in perception. Using psychophysical experiments and novel visual modulation techniques, investigators have probed the brain's visual systems responsible for global and local processing and found early evidence that they may be modifiable in BDD. These techniques include a "top-down" attentional modulation and a "bottom-up" perceptual modulation strategy. Abnormal eye gaze and emotional arousal when viewing faces may further contribute to abnormal perception. Whether these brain and behavior abnormalities are directly linked to abnormal perception remains to be understood. Accordingly, this study will determine a) if abnormalities in neural activation and connectivity in BDD when viewing one's own appearance are directly associated with abnormalities in perceptual functioning; and b) if changes in neural activation and connectivity from these visual modulation strategies are linked to changes in perceptual functioning, thus representing potential biomarkers. Investigators will also determine how attentional systems, eye gaze behaviors and emotional arousal interact with brain functioning in visual systems, and with global and local perceptual functioning. Investigators will enroll participants with BDD, with subclinical BDD, and healthy controls who will undergo functional magnetic resonance imaging while viewing photographs of own, and others' faces. Investigators will obtain measures of global and local visual processing, emotional arousal while participants view own face, and eye gaze behaviors using eye tracking. To understand the malleability of global/local perception, and the neural mechanisms of these changes, investigators will determine whether repeated visual modulation using top-down and bottom-up strategies results in alterations of perceptual functioning and brain activity/connectivity, and relationships between them. Results will provide a comprehensive mechanistic model of abnormal visual information processing underlying the core symptom domain of misperceptions of appearance. This will lay the groundwork for next-step translational approaches.

Connect with a study center

  • Centre for Addiction and Mental Health

    Toronto, Ontario M6J 1H3
    Canada

    Active - Recruiting

  • UCLA

    Los Angeles, California 90095
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.